Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerization

Abstract Background Vagus nerve stimulation (VNS) brings new hope for handling stroke. Our previous study confirmed that VNS could reduce neuronal pyroptosis and improve stroke prognosis. However, how VNS suppresses pyroptosis remains poorly understood. Osteopontin (OPN,SPP1) plays a neuroprotective...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Wen, Hao Tang, Ling Wang, Qinghuan Yang, Yong Zhao, Yu Ren, Ting Qin, Xuemei Li, Jianfeng Xu, Gongwei Jia, Qin Yang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-025-04242-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849343711759040512
author Jun Wen
Hao Tang
Ling Wang
Qinghuan Yang
Yong Zhao
Yu Ren
Ting Qin
Xuemei Li
Jianfeng Xu
Gongwei Jia
Qin Yang
author_facet Jun Wen
Hao Tang
Ling Wang
Qinghuan Yang
Yong Zhao
Yu Ren
Ting Qin
Xuemei Li
Jianfeng Xu
Gongwei Jia
Qin Yang
author_sort Jun Wen
collection DOAJ
description Abstract Background Vagus nerve stimulation (VNS) brings new hope for handling stroke. Our previous study confirmed that VNS could reduce neuronal pyroptosis and improve stroke prognosis. However, how VNS suppresses pyroptosis remains poorly understood. Osteopontin (OPN,SPP1) plays a neuroprotective role. Therefore, this study aims to determine whether vagus nerve stimulation (VNS) inhibits pyroptosis and promotes recovery from cerebral ischemic injury through osteopontin (OPN), and to elucidate the mechanisms by which OPN regulates pyroptosis. Methods Acute ischemic stroke (AIS) patients and healthy controls were recruited. The middle cerebral artery ischemia–reperfusion (MCAO/R) model of rats in vivo, the oxygen–glucose deprivation and reperfusion (OGD/R) and lipopolysaccharide (LPS) + adenosine triphosphate (ATP) models of microglia in vitro were established. Gene analysis of GEO public dataset (GSE61616), analysis of proteomics, western blotting, Co-immunoprecipitation (Co-IP) analysis, immunofluorescence staining, ELISA, TTC staining, TUNEL staining, transmission electron microscopy (TEM), scanning electron microscopy (SEM) and neurological function score were used to examinate expressions or concentrations of osteopontin, pyroptosis-related molecules, OPN-ASC interaction, infarct volume, neurological function, cell membrane pore, respectively. Results In MCAO/R rats and AIS patients, osteopontin levels were elevated. Intranasally administered recombinant osteopontin (rOPN) and VNS reduced pyroptosis and improved neurological deficits. VNS upregulated osteopontin expression in MCAO/R rats and AIS patients. Small interfering OPN RNA (siOPN) reversed effects of VNS on pyroptosis and outcome of MCAO/R injury in rats. The binding energy of OPN and ASC was -11.7 kcal/mol. LPS + ATP enhanced OPN-ASC interaction, and rOPN interfered with ASC oligomerization. Conditioned medium of microglia treated with rOPN reversed LPS + ATP-induced neruonal injury. Collectively, OPN may serve as a potential mediator through which VNS inhibits pyroptosis and improves the outcome of ischemic stroke, thereby representing a promising therapeutic target for stroke treatment. Conclusions These findings suggest that VNS alleviates pyroptosis and improves the outcome of cerebral ischemic stroke by upregulating osteopontin (OPN), which interferes with ASC oligomerization. Graphical Abstract
format Article
id doaj-art-439a2843a3fb4d03a2b9de59d1ca77a3
institution Kabale University
issn 1741-7015
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Medicine
spelling doaj-art-439a2843a3fb4d03a2b9de59d1ca77a32025-08-20T03:42:53ZengBMCBMC Medicine1741-70152025-07-0123112110.1186/s12916-025-04242-4Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerizationJun Wen0Hao Tang1Ling Wang2Qinghuan Yang3Yong Zhao4Yu Ren5Ting Qin6Xuemei Li7Jianfeng Xu8Gongwei Jia9Qin Yang10Department of Neurology, The Frist Affiliated Hospital of Chongqing Medical University, Yuzhong DistrictDepartment of Neurology, The Frist Affiliated Hospital of Chongqing Medical University, Yuzhong DistrictDepartment of Neurology, The Frist Affiliated Hospital of Chongqing Medical University, Yuzhong DistrictDepartment of Neurology, The Frist Affiliated Hospital of Chongqing Medical University, Yuzhong DistrictDepartment of Neurology, The Frist Affiliated Hospital of Chongqing Medical University, Yuzhong DistrictDepartment of Neurology, The Frist Affiliated Hospital of Chongqing Medical University, Yuzhong DistrictDepartment of Respiratory Disease, Daping Hospital, Army Medical UniversityDepartment of Neurology, The Second People’s Hospital of Chongqing Banan DistrictDepartment of Neurosurgery, The Third People’s Hospital of MianyangDepartment of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical UniversityDepartment of Neurology, The Frist Affiliated Hospital of Chongqing Medical University, Yuzhong DistrictAbstract Background Vagus nerve stimulation (VNS) brings new hope for handling stroke. Our previous study confirmed that VNS could reduce neuronal pyroptosis and improve stroke prognosis. However, how VNS suppresses pyroptosis remains poorly understood. Osteopontin (OPN,SPP1) plays a neuroprotective role. Therefore, this study aims to determine whether vagus nerve stimulation (VNS) inhibits pyroptosis and promotes recovery from cerebral ischemic injury through osteopontin (OPN), and to elucidate the mechanisms by which OPN regulates pyroptosis. Methods Acute ischemic stroke (AIS) patients and healthy controls were recruited. The middle cerebral artery ischemia–reperfusion (MCAO/R) model of rats in vivo, the oxygen–glucose deprivation and reperfusion (OGD/R) and lipopolysaccharide (LPS) + adenosine triphosphate (ATP) models of microglia in vitro were established. Gene analysis of GEO public dataset (GSE61616), analysis of proteomics, western blotting, Co-immunoprecipitation (Co-IP) analysis, immunofluorescence staining, ELISA, TTC staining, TUNEL staining, transmission electron microscopy (TEM), scanning electron microscopy (SEM) and neurological function score were used to examinate expressions or concentrations of osteopontin, pyroptosis-related molecules, OPN-ASC interaction, infarct volume, neurological function, cell membrane pore, respectively. Results In MCAO/R rats and AIS patients, osteopontin levels were elevated. Intranasally administered recombinant osteopontin (rOPN) and VNS reduced pyroptosis and improved neurological deficits. VNS upregulated osteopontin expression in MCAO/R rats and AIS patients. Small interfering OPN RNA (siOPN) reversed effects of VNS on pyroptosis and outcome of MCAO/R injury in rats. The binding energy of OPN and ASC was -11.7 kcal/mol. LPS + ATP enhanced OPN-ASC interaction, and rOPN interfered with ASC oligomerization. Conditioned medium of microglia treated with rOPN reversed LPS + ATP-induced neruonal injury. Collectively, OPN may serve as a potential mediator through which VNS inhibits pyroptosis and improves the outcome of ischemic stroke, thereby representing a promising therapeutic target for stroke treatment. Conclusions These findings suggest that VNS alleviates pyroptosis and improves the outcome of cerebral ischemic stroke by upregulating osteopontin (OPN), which interferes with ASC oligomerization. Graphical Abstracthttps://doi.org/10.1186/s12916-025-04242-4Ischemic strokeVagus nerve stimulationOsteopontinPyroptosisASC
spellingShingle Jun Wen
Hao Tang
Ling Wang
Qinghuan Yang
Yong Zhao
Yu Ren
Ting Qin
Xuemei Li
Jianfeng Xu
Gongwei Jia
Qin Yang
Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerization
BMC Medicine
Ischemic stroke
Vagus nerve stimulation
Osteopontin
Pyroptosis
ASC
title Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerization
title_full Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerization
title_fullStr Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerization
title_full_unstemmed Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerization
title_short Vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin (SPP1) to disturb ASC oligomerization
title_sort vagus nerve stimulation inhibits pyroptosis and improves outcome of cerebral ischemic stroke by upregulating osteopontin spp1 to disturb asc oligomerization
topic Ischemic stroke
Vagus nerve stimulation
Osteopontin
Pyroptosis
ASC
url https://doi.org/10.1186/s12916-025-04242-4
work_keys_str_mv AT junwen vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT haotang vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT lingwang vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT qinghuanyang vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT yongzhao vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT yuren vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT tingqin vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT xuemeili vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT jianfengxu vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT gongweijia vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization
AT qinyang vagusnervestimulationinhibitspyroptosisandimprovesoutcomeofcerebralischemicstrokebyupregulatingosteopontinspp1todisturbascoligomerization